Is Increasing Antibiotic Resistance Driving Bacteriophage Therapy Closer to Being a Reality?
By Max Sherman -
Published 14 August 2017
This article reviews the history of bacteriophage discovery, biology, and potential medical uses, and discusses therapeutic pros and cons compared to and potentially replacing antibiotics due to increasing antibiotic resistance. The article also highlights the future of phage therapy and the need for more scientific investigation and clinical trials prior to approval for human use and the possible patenting and regulatory issues impacting bacteriophage development. The US Food and Drug Administration (FDA) recently covered issues related to bacteriophage development during a workshop in July 2017.
Categories: Features, FDA, Biologics and biotechnology
Tags: Bacteriophage, Phage, Antimicrobial Resistance
AmpliPhi Biosciences Gets First cGMP Certification for Bacteriophage Facility
By Michael Mezher -
Published 04 June 2015
AmpliPhi Biosciences announced Wednesday it has received the first ever good manufacturing practices certification for its bacteriophage facility in Slovenia.
Categories: News, Europe, Biologics and biotechnology, Manufacturing, Regulatory strategy, Research and development
Tags: Phage therapy, Bacteriophage, antimicrobial resistance, Good manufacturing practice, GMP